ESTRO 2024 - Abstract Book

S2219

Clinical - Upper GI

ESTRO 2024

Conclusion:

In this preliminary analysis, adjuvant SBRT in pancreatic cancer proved to be a safe and well tolerated approach without ≥G3 toxicity. We will await the final results to confirm these data.

Keywords: SBRT, Pancreatic cancer, Adjuvant therapy

1981

Digital Poster

Spleen and vertebral body dose associations with lymphopenia after ablative pancreas radiotherapy

Michael D Chuong 1 , Robert Herrera 1 , Nicolas Carvallo 1 , Muni Rubens 1 , Rupesh Kotecha 1 , Matthew D Hall 1 , Kathryn E Mittauer 1 , Nema Bassiri-Gharb 1 , Alonso N Gutierrez 2 , Adeel Kaiser 1

1 Miami Cancer Institute, Radiation Oncology, Miami, USA. 2 Miami Cancer Institue, Radiation Oncology, Miami, USA